-
2023
-
van der Arend BWH, Verhagen IE, van Leeuwen M, van der Arend MQTP, van Casteren DS, Terwindt GM.
Defining migraine days, based on longitudinal E-diary data
Cephalalgia. 2023 May
Show the publication
-
- Migraine
- Research on genetics
- Results
Harder AVE, Terwindt GM, Nyholt DR, van den Maagdenberg AMJM.
Migraine genetics: Status and road forward
Cephalalgia. 2023 Feb;43(2):3331024221145962
Show the publication
-
Ashina S, Terwindt GM, Steiner TJ, Ji Lee M, Porreca F, Tassorelli C, Schwedt TJ, Jensen RH, Diener H, Lipton RB
Medication overuse headache
Nat Rev Dis Primers. 2023 Feb 2
Show the publication
-
Mehta, D., de Boer, I., Sutherland, H.G., Pijpers, J.A., Bron, C., Bainomugisa, C., Haupt, L.M., van den Maagdenberg, A.M.J.M., Griffiths, L.R., Nyholt, D.R., Terwindt, G.M.
Alterations in DNA methylation associate with reduced migraine and headache days after medication withdrawal treatment in chronic migraine patients: a longitudinal study
Clin Epigenet 15, 190 (2023).
Show the publication
-
2022
-
de Vries Lentsch S, van der Arend BWH, Maassen VanDenBrink A, Terwindt GM
Blood Pressure in Patients With Migraine Treated With Monoclonal Anti-CGRP (Receptor) Antibodies: A Prospective Follow-up Study
Neurology. 2022;99(17):e1897-e904
Show the publication
-
de Vries Lentsch S, Al-Hassany L, Ferrari MD, Terwindt GM, MaassenVanDenBrink A
CGRP-mediated trigeminovascular reactivity in migraine patients treated with erenumab
Journal of neurology, neurosurgery, and psychiatry. 2022;93(8):911-912
Show the publication
-
de Vries Lentsch S, Louter MA, van Oosterhout W, van Zwet EW, van Noorden MS, Terwindt GM
Depressive symptoms during the different phases of a migraine attack: A prospective diary study
Journal of Affective Disorders. 2022;297:502-507
Show the publication
-
de Vries Lentsch S, Garrelds IM, Danser AHJ, Terwindt GM, MaassenVanDenBrink A
Serum CGRP in migraine patients using erenumab as preventive treatment
The journal of headache and pain. 2022;23(1):120
Show the publication
